ATS 2024 Final Program

Click on the session title to view the speakers

334

WEDNESDAY • MAY 22

11:04 Impact of Private Equity Acquisitions on ICU Utilization and ICU Operations 11:12 Effect of Nursing Shortages on ICU Operations 11:20 Comparison of International ICU Costs (to Patients or Providers) 11:28 Impact of ICU Care on Ability to Afford Future Medical Care for Patients and Their Families. 11:36 Effects of ICU Capacity Strain on Hospital Operations 11:44 Association of NICU Admission with Changes in Financial Status 11:52 Sociology of Health Shocks, Financial Toxicity, and Interventions: Implications for Critical Illness 12:00 Panel and General Discussion 12:20 Transition Time

Wednesday Afternoon, May 22

CLINICAL CRITICAL CARE TRACK

BASIC • CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE

D81 MONEY AND THE ICU: FINANCIAL MOTIVATORS AND CONSEQUENCES OF CRITICAL CARE Assemblies on Critical Care; Behavioral and Health Services Research; Nursing 11:00 a.m. - 12:30 p.m. San Diego Convention Center Room 7A-B (Upper Level) Target Audience All providers of critical care Objectives At the conclusion of this session, the participant will be able to: • describe new findings about the cost of critical care to patients • describe the impact of financial incentives on ICU utilization • apply knowledge about financial incentives for healthcare systems to better optimize ICU triage Critical care delivery has financial implications for patients, payers, and providers. Because ICU care is expensive, understanding the costs to society and to patients is important. This session will highlight recent research into understanding both how financial incentives impact ICU utilization and the financial consequences of ICU utilization on various stakeholders in the healthcare system. 11:00 Introductory Remarks

D82 WHO WHAT WHERE WHY HOW?

INHALATIONAL EXPOSURES AND ILD

Assemblies on Clinical Problems; Environmental, Occupational and Population Health 11:00 a.m. - 12:30 p.m.

San Diego Convention Center Ballroom 20A (Upper Level)

Target Audience Pulmonary medicine providers and trainees would both benefit from this session. Specifically, any individual desiring to broaden their knowledge of ILD evaluation and pathogenesis through the lens of inhalational exposures will be the target audience. Objectives At the conclusion of this session, the participant will be able to: • identify relevant inhaled risk factors for ILD • understand the pathobiology and mechanisms by which exposures cause and propogate ILD • recognize assessment methods that exist for clinical identification of inhalational exposures in individual ILD patients A growing body of evidence demonstrates the contributions of environmental and occupational exposures to many forms of interstitial lung disease (ILD), from increased risk of disease

ATS 2024 • San Diego, CA